SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-15-001037
Filing Date
2015-02-13
Accepted
2015-02-13 16:13:25
Documents
14
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q1214_relmadatherap.htm 10-Q 394580
2 CERTIFICATE OF AMENDMENT TO ARTICLES OF INCORPORATION f10q1214ex3i_relmada.htm EX-3.1 1517
3 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER f10q1214ex31i_relmada.htm EX-31.1 19091
4 CERTIFICATION OF PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER f10q1214ex31ii_relmada.htm EX-31.2 18889
5 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER f10q1214ex32i_relmada.htm EX-32.1 7686
6 CERTIFICATION OF PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER f10q1214ex32ii_relmada.htm EX-32.2 8292
13 GRAPHIC ex3i.jpg GRAPHIC 192439
14 GRAPHIC ex3ii.jpg GRAPHIC 28081
  Complete submission text file 0001213900-15-001037.txt   4696746

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE relm-20141231.xml EX-101.INS 725059
8 XBRL SCHEMA FILE relm-20141231.xsd EX-101.SCH 30269
9 XBRL CALCULATION FILE relm-20141231_cal.xml EX-101.CAL 20784
10 XBRL DEFINITION FILE relm-20141231_def.xml EX-101.DEF 121501
11 XBRL LABEL FILE relm-20141231_lab.xml EX-101.LAB 281345
12 XBRL PRESENTATION FILE relm-20141231_pre.xml EX-101.PRE 193734
Mailing Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-702-7163
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

IRS No.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-55347 | Film No.: 15614642
SIC: 2834 Pharmaceutical Preparations